Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P9LO
|
||||
Former ID |
DIB011760
|
||||
Drug Name |
BP-2.94
|
||||
Synonyms |
FUB-94; (-)-2-[1-[2-(4-Imidazolyl)-1(R)-methylethylimino]-1-phenylmethyl]phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Discontinued in Phase 2 | [546450] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H19N3O
|
||||
Canonical SMILES |
CC(CC1=CN=CN1)NC(=C2C=CC=CC2=O)C3=CC=CC=C3
|
||||
InChI |
1S/C19H19N3O/c1-14(11-16-12-20-13-21-16)22-19(15-7-3-2-4-8-15)17-9-5-6-10-18(17)23/h2-10,12-14,22H,11H2,1H3,(H,20,21)/b19-17+
|
||||
InChIKey |
NDSIMLLWOSEGGX-HTXNQAPBSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Modulator | [534203] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.